selected publications
- A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV. 2024 GET IT
- Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative. Journal of clinical and translational science. 2024 Review GET IT
- Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial. The Journal of infectious diseases. 2024 Academic Article GET IT
- The Impact of Aging on HIV-1-related Neurocognitive Impairment. Ageing research reviews. 2024 Review GET IT
- Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial. EClinicalMedicine. 2024 Academic Article GET IT
- Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Academic Article GET IT
- Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2. The Journal of infectious diseases. 2024 Academic Article GET IT
- Cellular rejuvenation to combat HIV-1-related neurocognitive impairment. Trends in microbiology. 2023 Academic Article GET IT
- Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City. Antibiotics (Basel, Switzerland). 2023 Academic Article GET IT
- Long COVID After Bamlanivimab Treatment. The Journal of infectious diseases. 2023 Academic Article GET IT
-
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.
Frontiers in cellular neuroscience.
2023
Academic Article
GET IT
Times cited: 6 - Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Annals of internal medicine. 2023 Academic Article GET IT
- Transposable elements and Alzheimer's disease pathogenesis. Trends in neurosciences. 2022 Academic Article GET IT
- Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Academic Article GET IT
- Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Infectious disease clinics of North America. 2022 Review GET IT
- Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Staphylococcus Aureus Infection Recurrence: CA-MRSA Project (CAMP2). Progress in community health partnerships : research, education, and action. 2022 Academic Article GET IT
- Comparative Effectiveness Study of Home-Based Interventions to Prevent CA-MRSA Infection Recurrence. Antibiotics (Basel, Switzerland). 2021 Academic Article GET IT
-
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.
Allergy.
2021
Academic Article
GET IT
Times cited: 40 -
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
Journal of virology.
2020
Academic Article
GET IT
Times cited: 5 -
Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
Current HIV/AIDS reports.
2018
Information Resource
GET IT
Times cited: 2 -
Helping Basic Scientists Engage With Community Partners to Enrich and Accelerate Translational Research.
Academic medicine : journal of the Association of American Medical Colleges.
2017
Academic Article
GET IT
Times cited: 32 -
Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.
Travel medicine and infectious disease.
2016
Academic Article
GET IT
Times cited: 12 -
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.
The Journal of infectious diseases.
2016
Academic Article
GET IT
Times cited: 11 -
From the Bench to the Barbershop: Community Engagement to Raise Awareness About Community-Acquired Methicillin-Resistant Staphylococcus aureus and Hepatitis C Virus Infection.
Progress in community health partnerships : research, education, and action.
2016
Academic Article
GET IT
Times cited: 7 -
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
AIDS (London, England).
2016
Academic Article
GET IT
Times cited: 13 -
Molecular Types of Methicillin-Resistant Staphylococcus aureus and Methicillin-Sensitive S. aureus Strains Causing Skin and Soft Tissue Infections and Nasal Colonization, Identified in Community Health Centers in New York City.
Journal of clinical microbiology.
2015
Academic Article
GET IT
Times cited: 28 -
Recurrent furunculosis caused by a community-acquired Staphylococcus aureus strain belonging to the USA300 clone.
Microbial drug resistance (Larchmont, N.Y.).
2015
Academic Article
GET IT
Times cited: 10 - Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users. Journal of addiction research & therapy. 2015 Academic Article GET IT
-
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.
Retrovirology.
2014
Academic Article
GET IT
Times cited: 20 -
Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.
Journal of acquired immune deficiency syndromes (1999).
2012
Academic Article
GET IT
Times cited: 36 -
Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
PLoS pathogens.
2012
Academic Article
GET IT
Times cited: 100 -
Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis.
Cell cycle (Georgetown, Tex.).
2007
Academic Article
GET IT
Times cited: 66 -
The immunology of parasite infections in immunocompromised hosts.
Parasite immunology.
2006
Information Resource
GET IT
Times cited: 74 -
Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.
Immunology.
2006
Academic Article
GET IT
Times cited: 28